A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

According to the Mayo Clinic, most weight loss occurs within the first four to five months of use. Long-term use of weight loss drugs can lead to sustained weight decreases and improvements in overall ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...

HIMS posted stellar Q1 FY 2025; growth fueled by ~2.4M subscribers and $84 average monthly revenue per user. Click here to ...

Eli Lilly's growth is impressive, but its current valuation is only justifiable with sustained high growth. Click here to ...

The MUSC Weight Management Center (WMC) is casting a lifeline to plus-sized individuals at wit's end with their apple cider ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

I’ve always been overweight, even as a child. Growing up in the 90s and early 2000s, I was surrounded by images of ultra-thin pop stars in low-rise jeans and crop tops. I remember being told, "That ...

Regional equity markets closed in positive territory on Tuesday, building positive momentum after a muted trading session on ...

EMBRACED WEIGHT LOSS DRUGS Novo Nordisk's Wegovy, approved by the FDA for chronic weight management in 2021, was the first time a single medication was available that helped patients shed more ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the ...